Femasys Inc FEMY
We take great care to ensure that the data presented and summarized in this overview for FEMASYS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding FEMY
View all-
Cm Management, LLC425KShares$467,5000.4% of portfolio
-
Clear Creek Financial Management, LLC307KShares$337,2860.04% of portfolio
-
Geode Capital Management, LLC Boston, MA206KShares$227,1310.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA193KShares$211,9330.0% of portfolio
-
Northern Trust Corp Chicago, IL88.4KShares$97,2630.0% of portfolio
-
State Street Corp Boston, MA56.4KShares$62,0050.0% of portfolio
-
Royal Bank Of Canada Toronto, A652.9KShares$58,2280.0% of portfolio
-
Black Rock Inc. New York, NY35.7KShares$39,2450.0% of portfolio
-
Hb Wealth Management, LLC35.5KShares$39,0140.0% of portfolio
-
Xtx Topco LTD London, X032.5KShares$35,7880.0% of portfolio
Latest Institutional Activity in FEMY
Top Purchases
Top Sells
About FEMY
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
Insider Transactions at FEMY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
William Benson Witte |
BUY
Other acquisition or disposition
|
Direct |
12,191
+50.0%
|
-
|
|
Dec 15
2021
|
John Dyett |
BUY
Other acquisition or disposition
|
Indirect |
175,635
+37.69%
|
-
|
|
Dec 15
2021
|
John Dyett |
SELL
Other acquisition or disposition
|
Indirect |
3,219,795
-100.0%
|
-
|
|
Jun 23
2021
|
John Dyett |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.86%
|
$9,000
$9.95 P/Share
|
|
Jun 22
2021
|
John Q Adams Jr |
BUY
Conversion of derivative security
|
Direct |
199,938
+36.09%
|
-
|
|
Jun 22
2021
|
John Q Adams Jr |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$520,000
$13.0 P/Share
|
|
Jun 22
2021
|
Charles Larsen |
BUY
Conversion of derivative security
|
Direct |
10,587
+37.58%
|
-
|
|
Jun 22
2021
|
Charles Larsen |
BUY
Open market or private purchase
|
Direct |
7,000
+50.0%
|
$91,000
$13.0 P/Share
|
|
Jun 22
2021
|
Edward R Uzialko |
BUY
Conversion of derivative security
|
Indirect |
30,175
+50.0%
|
-
|
|
Jun 22
2021
|
Edward R Uzialko |
BUY
Conversion of derivative security
|
Direct |
1,059,445
+47.16%
|
-
|
|
Jun 22
2021
|
Edward R Uzialko |
BUY
Open market or private purchase
|
Direct |
100,000
+43.9%
|
$1,300,000
$13.0 P/Share
|
|
Jun 22
2021
|
John Dyett |
BUY
Conversion of derivative security
|
Indirect |
3,283,504
+42.42%
|
-
|
|
Jun 22
2021
|
John Dyett |
BUY
Open market or private purchase
|
Indirect |
40,000
+44.44%
|
$520,000
$13.0 P/Share
|
|
Jun 18
2021
|
John Dyett |
BUY
Open market or private purchase
|
Indirect |
12,500
+50.0%
|
$162,500
$13.03 P/Share
|